Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera Receives Authorization From Health Canada To Initiate Phase 1 Clinical Trial Of ABCL575

May 30 (Reuters) - Abcellera Biologics Inc ABCL.O:

ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE A PHASE 1 CLINICAL TRIAL OF ABCL575

ABCELLERA BIOLOGICS INC - PHASE 1 CLINICAL TRIAL FOR ABCL575 TO START IN Q3 2025

Source text: ID:nBw4WscWBa

Further company coverage: ABCL.O

 (((( Reuters.Briefs@thomsonreuters.com ;));))

Recent news on AbCellera Biologics

See all news